Gene therapy shot for arthritic knees enters human testing
NCT ID NCT07198555
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new gene therapy called BBM-A101 for people with moderate knee osteoarthritis. The main goal is to check if it is safe and tolerable. About 81 adults with knee pain and joint changes will receive the treatment and be monitored for side effects and any signs of improvement.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shenzhen Second People's Hospital
RECRUITINGShenzhen, Guangdong, 518035, China
-
The Ninth People's Hospital of Shanghai Jiao Tong University School of Medicine
RECRUITINGShanghai, Shanghai Municipality, 200011, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Low-Carb diet ease knee pain? a study investigates racial differences
- Blocking knee blood vessels may offer new pain relief for severe osteoarthritis
- Which knee implant lasts longer? a Head-to-Head test
- Can cutting carbs curb knee pain? a diet trial puts it to the test
- Can virtual reality make knee pain therapy more engaging?
- Can a stem cell shot rebuild Worn-Out knees?